Page last updated: 2024-08-16

ribavirin and Chronic Disease

ribavirin has been researched along with Chronic Disease in 121 studies

Research

Studies (121)

Timeframe	Studies, this research(%)	All Research%
pre-1990	5 (4.13)	18.7374
1990's	44 (36.36)	18.2507
2000's	37 (30.58)	29.6817
2010's	33 (27.27)	24.3611
2020's	2 (1.65)	2.80

Authors

Authors	Studies
Nagaraju, SP; Nair N, S; Pai, G; Prabhu, AR; Rajwar, E; Rao, IR; Reddy, NP; Suvarna, D; Venkatesh, BT	1
Dhanda, A; Moodley, P; Whyte, AF	1
Descalzi, VI; González, J; Gruz, F; Lizarraga Villagran, MA; Munné, MS; Raffaele, PP	1
Abravanel, F; Akhavan, S; Calmus, Y; Conti, F; Guillemain, R; Lecuyer, L; Marcelin, AG; Mazzola, A; Peytavin, G; Poynard, T; Roque-Afonso, AM; Todesco, E	1
Häffner, K; Klämbt, V; Panning, M; Pohl, M; Seidl, M	1
Kamar, N; Pischke, S	1
Abravanel, F; Cointault, O; Del Bello, A; Esposito, L; Hébral, AL; Izopet, J; Kamar, N; Lavayssière, L; Lhomme, S; Marion, O; Ribes, D	1
Bladé, JS; Boudin, L; de Jauréguiberry, JP; Patient, M; Roméo, E; Tsitsi Nding Tsogou, P	1
Abravanel, F; Izopet, J; Kamar, N; Marion, O	1
Chtioui, H; Fraga, M; Gouttenoire, J; Marcu, C; Moradpour, D; Pascual, M; Sahli, R; Vionnet, J	1
Horvatits, T; Lohse, AW; Lütgehetmann, M; Pischke, S; Schulze Zur Wiesch, J	1
Hopwood, M	1
Horváth, G; Hunyady, B; Makara, M; Szalay, F; Tornai, I	1
Rakela, J; Unzueta, A	1
Bremer, B; Gisa, A; Gottlieb, J; Greer, M; Hardtke, S; Haverich, A; Lehmann, P; Manns, MP; Pischke, S; Wedemeyer, H; Welte, T	1
Herbst, DA; Pavri, TM; Reddy, KR	1
Kainulainen, L; Ruuskanen, O; Waris, M	1
Abravanel, F; Bismuth, M; Buchler, M; Coilly, A; Couzi, L; D'Alteroche, L; Dharancy, S; Dumortier, J; Garrigue, V; Hillaire, S; Hourmant, M; Izopet, J; Kamar, N; Lebray, P; Mallet, V; Minello, A; Pol, S; Radenne, S; Roque-Afonso, AM; Rostaing, L; Tripon, S	1
Gane, E; Hunt, SL; Jacobson, IM; Lawitz, E; Nader, F; Nelson, D; Stepanova, M; Younossi, ZM	1
Boots, JM; de Man, R; de Vries, MA; Samijn, JP	1
Aravinthan, A; Bandoh, BN; Cordero-Ng, AY; Curran, MD; Davies, S; Gkrania-Klotsas, E; Kumararatne, D; Liu, H; Stevenson, P; Woodward, JM; Zhang, H	1
Castedal, M; Karason, K; Konar, J; Lagging, M; Norder, H; Waldenström, J	1
Dao Thi, VL; Debing, Y; Gouttenoire, J; Moradpour, D; Neyts, J; Rice, CM; Wu, X	1
Behrendt, P; Bock, CT; Bremer, B; Brown, RJ; Cornberg, M; Gisa, A; Manns, MP; Nitsche, A; Pischke, S; Radonic, A; Steinmann, E; Suneetha, PV; Todt, D; Wedemeyer, H	1
Cheng, Y; Ding, N; Jin, X; Qing, S; Wang, J; Xin, S; Yan, T; Zhao, P	1
Gkrania-Klotsas, E; Kumararatne, D; Woodward, J	1
Gilgenkrantz, H; Gouttenoire, J; Mallet, V	1
Ebner, N; Fischer, G; Jachmann, CA; Matzenauer, C; Thau, K; Wanner, C; Winklbaur, B	1
Esposito, L; Guitard, J; Kamar, N; Ribes, D; Rostaing, L	1
Sherman, KE	1
Chakvetadze, C; Mallet, V; Mouthon, L; Nicand, E; Pol, S; Sogni, P; Sultanik, P; Tessé, S; Thervet, E	1
Abravanel, F; Alric, L; Basse, G; Cointault, O; Esposito, L; Garrouste, C; Izopet, J; Kamar, N; Lhomme, S; Nogier, MB; Peron, JM; Ribes, D; Rostaing, L	1
Chaillon, A; d'Alteroche, L; De Muret, A; Goudeau, A; Nicand, E; Sirinelli, A	1
Chainuvati, S; Charatcharoenwitthaya, P; Kachintorn, U; Leelakusolvong, S; Limwongse, C; Manatsathit, S; Nimanong, S; Pausawasdi, N; Pithukpakorn, M; Pongprasobchai, S; Prachayakul, V; Tanwandee, T; Udompunturak, S; Vipatakul, N	1
Alric, L; Beynes-Rauzy, O; Bonnet, D; Izopet, J; Kamar, N	1
Corouge, M; Mallet, VO; Pol, S; Vallet-Pichard, A	1
Takeda, T	1
Ahmed, SN; Baulieux, J; Bizollon, T; Chevallier, M; Chevallier, P; Ducerf, C; Guichard, S; Parvaz, P; Radenne, S; Trepo, C; Zoulim, F	1
Yano, K; Yano, M; Yatsuhashi, H	1
Banks, A; Castro, O; Giday, S; Hasan, S; Hassan, M; Smoot, D	1
Burckhardt, B; Reichen, J	1
Copley, L	1
de Knegt, RJ; Orlent, H; Schalm, SW; Veldt, BJ; Vrolijk, JM	1
Shibasaki, T	1
Pearlman, BL	1
Kawamura, A; Kukita, K; Saitou, M; Tuyuguchi, M	1
Badur, S; Besisik, F; Bozaci, M; Cakaloglu, Y; Danalioglu, A; Demir, K; Karaca, C; Kaymakoglu, S; Okten, A; Poturoglu, S	1
de Rave, S; Schalm, SW; Vrolijk, JM	1
Maier, KP	1
Ferenci, P; Formann, E; Gangl, A; Homoncik, M; Jilma, B; Peck-Radosavljevic, M; Sieghart, W	1
Dieterich, DT; Park, JS; Saraf, N	1
Mohsen, A; Norris, S	2
Betterle, C; Cozzolongo, R; Fabris, P; Lanzilotta, E; Manghisi, OG; Paola Albergoni, M	1
Buffet, C	1
Kallman, J; Kincaid, J; Younossi, Z	1
Tursi, A	1
Fukumoto, K; Kanemasa, K; Sakai, K; Sumida, Y; Yoshida, N	1
Axel, B; Berg, T; Bienek, B; Bruno, R; Clotet, B; Danta, M; Grünhage, F; Haerter, G; Klausen, G; Lutz, T; Mayr, C; Nattermann, J; Nischalke, HD; Rausch, M; Rockstroh, JK; Sauerbruch, T; Schewe, K; Spengler, U; Tural, C; Vogel, M	1
Bischof, T; Gonvers, JJ; Mullhaupt, B; Renner, EL; Wenger, C	1
Morelli, J; Senecal, DL	1
Chen, CH; Chiang, BL; Kao, CL; Lee, JH; Lin, YT; Wang, LC; Yang, YH	1
Saunders, JC	1
Thaler, H	1
Merigan, TC; Smith, CI	1
Conjeevaram, HS; Di Bisceglie, AM; Fried, MW; Hoofnagle, JH; Kleiner, DE; Mahaney, K; Park, Y; Sallie, R; Swain, M; Yurdaydin, C	1
Barbara, L; Brillanti, S; Deaville, R; Foli, M; Garson, J; Masci, C; Miglioli, M; Whitby, K	1
Davis, GL; Lau, JY; Lim, HL	1
Giffin, FJ; Greenough, A; Yüksel, B	1
Schvarcz, R; Sönnerborg, A; Weiland, O; Yun, ZB	1
Main, J	1
Di Bisceglie, AM; Hoofnagle, JH; Krawczynski, K	1
Bacon, BR; Di Bisceglie, AM; Hoofnagle, JH; Kleiner, DE	1
Braconier, JH; Frydén, A; Norkrans, G; Weiland, O	1
Reichard, O	1
Dhumeaux, D; Marcellin, P; Pawlotsky, JM; Trépo, C	1
Hino, K; Niwa, H; Sainokami, S	1
Trépo, C; Zoulim, F	1
Banks, SM; Beames, MP; Di Bisceglie, AM; Fong, TL; Fried, MW; Hoofnagle, JH; Park, Y; Swain, MG	1
Sherlock, S	3
Camps, J; Civeira, MP; García, N; Prieto, J; Riezu-Boj, JI	1
Reichard, O; Sönnerborg, A; Weiland, O; Yun, ZB	1
Buti, M; Esteban, R; Guardia, J; Jardi, R; Rodriguez, F	1
Higashi, Y; Ishikawa, T; Kakumu, S; Takayanagi, M; Wakita, T; Yoshioka, K	2
Dusheiko, GM; Zuckerman, AJ	1
Pirotte, J	1
James, DG	1
Dusheiko, GM	1
Acero, D; Adrados, M; Figa, M; González-Huix, F	1
Chinitz, MA	1
Chan, KW; Chen, DS; Chen, PJ; Chu, JS; Kao, JH; Lai, MY; Wang, JT; Yang, PM	1
Bailly, F; Bizollon, T; Trepo, C	1
Bassendine, M; Cuypers, T; Dhillon, A; Dusheiko, G; Fryden, A; Lee, C; Lelie, N; Main, J; Norkrans, G; Rassam, S; Reesink, H; Reichard, O; Sillikens, P; Telfer, P; Thomas, H; Watson, J; Weegink, C; Weiland, O	1
Alberti, A; Bellobuono, A; Brouwer, JT; Chemello, L; Ideo, G; Schalm, SW; Schwartz, R; Weiland, O	1
Bruguera, M	1
Najm, W	1
Bellobuono, A; Idéo, G; Mondazzi, L; Silini, E; Tempini, S; Vicari, F	1
Alberti, A; Bellobuono, A; Brouwer, JT; Cavalletto, L; Chemello, L; Hansen, BE; Ideo, G; Schalm, SW; Schvarcz, R; Weiland, O	1
Collins, ML; Davis, GL; Detmer, J; Kolberg, JA; Lau, JY; Mizokami, M; Orito, E; Qian, K; Urdea, MS	1
Clarke, G; Crowe, J; Fielding, JF; Sachithanandan, S	1
Bodenheimer, HC; Davis, GL; Lewis, JH; Lindsay, KL; Seeff, LB; Thung, SN	1
Almasio, P; Cammà, C; Craxì, A; Di Marco, V; Giunta, M	1
He, Y; Liu, W; Zeng, L	1
Blot, C; Mathurin, P; Moussalli, J; Opolon, P; Perrin, M; Plassart, F; Poynard, T; Thevenot, T	1
Delwaide, J	1
Clement, RP; Glue, P; Gupta, S; Salfi, M; Schenker, S; Zambas, D	1
Bréchot, C; Chaix, ML; Fontaine, H; Lagneau, JL; Pol, S	1
Altisent, C; Esteban, JI; Esteban, R; Guardia, J; Puig, L; Sauleda, S	1
Gorbakov, VV	1
Aguilar, C; Lucia, JF; Simón, MA	1
Fontana, RJ	1
Everard, ML; Milner, AD; Rigby, AS; Swarbrick, A	1
Albrecht, JK; Dienstag, JL; Garaud, JJ; Gordon, SC; Ling, MH; McHutchison, JG; Morgan, TR; Shad, JA	1
Koczorek, M	1
Dowling, JN; Guevarra, LO; Postic, B	1
Jain, S; Oxford, JS; Sherlock, S; Thomas, HC	1
Wohl, ME	1

Reviews

47 review(s) available for ribavirin and Chronic Disease

Article	Year
Interventions for dialysis patients with hepatitis C virus (HCV) infection. The Cochrane database of systematic reviews, 2023, 04-25, Volume: 4 Topics: Antiviral Agents; Chronic Disease; Hepacivirus; Hepatitis C; Humans; Interferons; Recurrence; Renal Dialysis; Renal Insufficiency, Chronic; Ribavirin	2023
Acute and Persistent Hepatitis E Virus Genotype 3 and 4 Infection: Clinical Features, Pathogenesis, and Treatment. Cold Spring Harbor perspectives in medicine, 2019, 07-01, Volume: 9, Issue:7 Topics: Acute Disease; Age Factors; Animals; Antiviral Agents; Chronic Disease; Disease Transmission, Infectious; Genotype; Hepatitis E; Hepatitis E virus; Humans; Immunocompromised Host; Ribavirin; Sex Factors; Transplant Recipients	2019
The Clinical Perspective on Hepatitis E. Viruses, 2019, 07-05, Volume: 11, Issue:7 Topics: Animals; Antiviral Agents; Chronic Disease; Female; Genotype; Hepatitis E; Hepatitis E virus; Humans; Immunocompromised Host; Pregnancy; Pregnancy Complications, Infectious; Ribavirin	2019
[Organizational characteristics of treatment for chronic hepatitis in Hungary: Hepatitis Registry and Priority Index]. Orvosi hetilap, 2013, Jul-21, Volume: 154, Issue:29 Topics: Antiviral Agents; Chronic Disease; Delivery of Health Care; Drug Therapy, Combination; Health Priorities; Hepatitis, Viral, Human; Humans; Hungary; Interferons; Liver Cirrhosis; Registries; Ribavirin; Risk Assessment; Risk Factors	2013
Hepatitis E infection in liver transplant recipients. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2014, Volume: 20, Issue:1 Topics: Animals; Chronic Disease; Disease Progression; Feces; Fibrosis; Food Microbiology; Hepatitis E; Humans; Immunosuppression Therapy; Interferons; Liver; Liver Failure; Liver Transplantation; Ribavirin; RNA, Viral	2014
Meta-Analysis of Combination Therapy of Chinese Herbs Plus Interferon and Ribavirin in Patients with Chronic Hepatitis C. Medical science monitor : international medical journal of experimental and clinical research, 2016, May-30, Volume: 22 Topics: Antiviral Agents; Chronic Disease; Complementary Therapies; Drug Therapy, Combination; Drugs, Chinese Herbal; Hepatitis C, Chronic; Humans; Interferons; Medicine, Chinese Traditional; Ribavirin; Treatment Outcome	2016
Chronic norovirus infection and common variable immunodeficiency. Clinical and experimental immunology, 2017, Volume: 188, Issue:3 Topics: Antiviral Agents; Caliciviridae Infections; Chronic Disease; Common Variable Immunodeficiency; Diarrhea; Duodenum; Humans; Immunoglobulins; Norovirus; Ribavirin; Tomography, X-Ray Computed	2017
Retention rate and side effects in a prospective trial on hepatitis C treatment with pegylated interferon alpha-2a and ribavirin in opioid-dependent patients. Addiction biology, 2009, Volume: 14, Issue:2 Topics: Adolescent; Adult; Aged; Antiviral Agents; Chronic Disease; Female; Genotype; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Opioid-Related Disorders; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Retention, Psychology; Ribavirin; Young Adult	2009
Thymosin alpha 1 for treatment of hepatitis C virus: promise and proof. Annals of the New York Academy of Sciences, 2010, Volume: 1194 Topics: Carcinoma, Hepatocellular; Chronic Disease; Clinical Trials as Topic; Hepacivirus; Humans; Interferons; Liver Cirrhosis; Liver Neoplasms; Neoplasms; Randomized Controlled Trials as Topic; Ribavirin; Thymalfasin; Thymosin; Treatment Outcome	2010
Hepatitis C: epidemiology, diagnosis, natural history and therapy. Contributions to nephrology, 2012, Volume: 176 Topics: Antiviral Agents; Chronic Disease; Hepacivirus; Hepatitis C; Humans; Incidence; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Prevalence; Protease Inhibitors; Recombinant Proteins; Ribavirin	2012
[Progress in blood purification medicine in 2011]. Nihon Jinzo Gakkai shi, 2012, Volume: 54, Issue:1 Topics: Antiviral Agents; Bone Diseases, Metabolic; Cardiovascular Diseases; Chronic Disease; Hepatitis C; HIV Infections; Humans; Interferons; Kidney Diseases; Practice Guidelines as Topic; Renal Dialysis; Ribavirin	2012
[Hepatitis C]. Nihon rinsho. Japanese journal of clinical medicine, 2003, Volume: 61 Suppl 2 Topics: Acute Disease; Chronic Disease; Drug Therapy, Combination; Hepacivirus; Hepatitis C; Humans; Interferons; Japan; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; RNA, Viral	2003
HCV in sickle cell disease. Journal of the National Medical Association, 2003, Volume: 95, Issue:9 Topics: Anemia, Sickle Cell; Antiviral Agents; Chronic Disease; Comorbidity; Disease Progression; Genotype; Hepacivirus; Hepatitis C; Humans; Interferons; Liver; Prevalence; Ribavirin; Transfusion Reaction; United States	2003
The treatment of hepatitis C: history, presence and future. The Netherlands journal of medicine, 2004, Volume: 62, Issue:3 Topics: Amantadine; Antiviral Agents; Chronic Disease; Consensus; Drug Therapy, Combination; Hepatitis C; Humans; Interferon-alpha; Practice Guidelines as Topic; Ribavirin	2004
[Chronic nephritic syndrome]. Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 6 Topics: Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Chronic Disease; Diagnosis, Differential; Diet, Protein-Restricted; Diet, Sodium-Restricted; Globins; Glomerulonephritis; Humans; Immunosuppressive Agents; Platelet Aggregation Inhibitors; Prednisolone; Ribavirin; Syndrome	2004
Hepatitis C treatment update. The American journal of medicine, 2004, Sep-01, Volume: 117, Issue:5 Topics: Acute Disease; Adjuvants, Immunologic; Algorithms; Antiviral Agents; Chronic Disease; Decision Trees; Disease Progression; Drug Monitoring; Drug Therapy, Combination; Forecasting; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Patient Compliance; Polyethylene Glycols; Prevalence; Recombinant Proteins; Ribavirin; RNA, Viral; Severity of Illness Index; Treatment Outcome; United States; Viral Load	2004
[Prevalence of hepatitis C virus infection among chronic hemodialysis patients]. Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 7, Issue:Pt 1 Topics: Antiviral Agents; Biomarkers; Chronic Disease; Hepacivirus; Hepatitis C; Hepatitis C Antibodies; Humans; Interferon-alpha; Prevalence; Renal Dialysis; Ribavirin; Risk; RNA, Viral; Time Factors; Transfusion Reaction	2004
[Drug therapy in chronic liver disease]. Praxis, 2005, Nov-30, Volume: 94, Issue:48 Topics: Adenine; Administration, Oral; Anti-HIV Agents; Antiviral Agents; Azathioprine; Cholangitis, Sclerosing; Chronic Disease; Drug Therapy, Combination; Fatty Liver; Hemochromatosis; Hepatitis B, Chronic; Hepatitis C, Chronic; Hepatitis, Autoimmune; Hepatolenticular Degeneration; Humans; Immunosuppression Therapy; Interferons; Lamivudine; Liver Cirrhosis, Biliary; Liver Diseases; Organophosphonates; Prednisolone; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Ribavirin; Time Factors	2005
HBV plus HCV, HCV plus HIV, HBV plus HIV. Current gastroenterology reports, 2006, Volume: 8, Issue:1 Topics: Algorithms; Antiviral Agents; Carcinoma, Hepatocellular; Chronic Disease; Disease Progression; Drug Interactions; Hepatitis B; Hepatitis C; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Viral Load	2006
Chronic hepatitis C. Clinical evidence, 2005, Issue:14 Topics: Antiviral Agents; Chronic Disease; Drug Therapy, Combination; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Interferons; Polyethylene Glycols; Recombinant Proteins; Ribavirin	2005
Hepatitis C (chronic). Clinical evidence, 2006, Issue:15 Topics: Antiviral Agents; Chronic Disease; Drug Therapy, Combination; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Interferons; Polyethylene Glycols; Recombinant Proteins; Ribavirin	2006
[Acute hepatitis. Biological hepatic anomalies in asymptomatic persons]. La Revue du praticien, 2006, Sep-15, Volume: 56, Issue:13 Topics: Acute Disease; Adult; Antiviral Agents; Cholestasis; Chronic Disease; Clinical Enzyme Tests; Diagnosis, Differential; France; Hepatitis A; Hepatitis B; Hepatitis B, Chronic; Hepatitis C; Hepatitis C, Chronic; Hepatitis D; Hepatitis D, Chronic; Hepatitis, Viral, Human; Humans; Infectious Disease Transmission, Vertical; Interferon-alpha; Phosphoric Monoester Hydrolases; Prevalence; Ribavirin; Transaminases	2006
The effects of HCV infection and management on health-related quality of life. Hepatology (Baltimore, Md.), 2007, Volume: 45, Issue:3 Topics: Antiviral Agents; Chronic Disease; Depression; Fatigue; Health Status; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Diseases; Polyethylene Glycols; Quality of Life; Recombinant Proteins; Ribavirin	2007
Hepatitis C virus infection: a current review. JAAPA : official journal of the American Academy of Physician Assistants, 2007, Volume: 20, Issue:10 Topics: Acute Disease; Antiviral Agents; Chronic Disease; Genotype; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Assessment; Risk Factors	2007
Neuropsychiatric symptoms of hepatitis C. Issues in mental health nursing, 2008, Volume: 29, Issue:3 Topics: Antiviral Agents; Anxiety Disorders; Brain; Chronic Disease; Cognition Disorders; Depressive Disorder, Major; Hepatitis C; Humans; Neuropsychological Tests; Ribavirin	2008
[New developments in therapy and prophylaxis of viral hepatitis (author's transl)]. Acta medica Austriaca, 1981, Volume: 7, Issue:2 Topics: Antiviral Agents; Chronic Disease; Hepatitis, Viral, Human; Humans; Immunization; Immunization, Passive; Immunosuppression Therapy; Immunosuppressive Agents; Interferons; Ribavirin; Vidarabine	1981
Therapeutic approaches to chronic hepatitis B. Progress in liver diseases, 1982, Volume: 7 Topics: Acyclovir; Adrenal Cortex Hormones; Antiviral Agents; Azathioprine; Chronic Disease; Guanine; Hepatitis B; Humans; Immunoglobulins; Interferons; Levamisole; Ribavirin; Transfer Factor; Vidarabine; Vidarabine Phosphate	1982
Therapy for chronic hepatitis C. Gastroenterology clinics of North America, 1994, Volume: 23, Issue:3 Topics: Chronic Disease; DNA, Viral; Dose-Response Relationship, Drug; Hepatitis C; Humans; Interferons; Recurrence; Ribavirin; RNA, Viral; Time Factors	1994
Hepatitis C: clinical aspects. The Journal of infection, 1995, Volume: 30, Issue:2 Topics: Acute Disease; Chronic Disease; Genotype; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Ribavirin	1995
[Treatment of viral hepatitis C]. Gastroenterologie clinique et biologique, 1994, Volume: 18, Issue:4 Topics: Acute Disease; Chronic Disease; Drug Therapy, Combination; Hepatitis C; Humans; Interferon Type I; Interferon-beta; Recombinant Proteins; Ribavirin	1994
[Therapy of chronic hepatitis other than interferon therapy]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1994, Feb-10, Volume: 83, Issue:2 Topics: Antiviral Agents; Chronic Disease; Drugs, Chinese Herbal; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepatitis; Humans; Interleukin-2; Prednisolone; Ribavirin; Vidarabine	1994
Nucleoside analogs in the treatment of chronic viral hepatitis. Efficiency and complications. Journal of hepatology, 1994, Volume: 21, Issue:2 Topics: Acyclovir; Chronic Disease; Hepatitis, Viral, Human; Humans; Nucleosides; Ribavirin; Vidarabine	1994
Treatment of chronic viral hepatitis. The Journal of antimicrobial chemotherapy, 1993, Volume: 32 Suppl A Topics: Acute Disease; Adrenal Cortex Hormones; Chronic Disease; Hepatitis B; Hepatitis C; Hepatitis D; Humans; Interferon-alpha; Ribavirin	1993
[Current knowledge in the treatment of chronic hepatitis C]. Revue medicale de Liege, 1995, Volume: 50, Issue:12 Topics: Age Factors; Antiviral Agents; Chronic Disease; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Prognosis; Ribavirin; Risk Factors	1995
Treatment options for chronic hepatitis C infection. The Journal of antimicrobial chemotherapy, 1995, Volume: 36, Issue:4 Topics: Antiviral Agents; Chronic Disease; Drug Therapy, Combination; Hepatitis C; Humans; Interferons; Randomized Controlled Trials as Topic; Ribavirin; Thymosin	1995
Antiviral therapy for chronic hepatitis C viral infection. Journal of hepatology, 1995, Volume: 23 Suppl 2 Topics: Antiviral Agents; Chronic Disease; Clinical Trials as Topic; Drug Therapy, Combination; Hepacivirus; Hepatitis C; Humans; Interferon Type I; Liver Cirrhosis; Liver Neoplasms; Patient Selection; Prevalence; Recombinant Proteins; Ribavirin; RNA, Viral	1995
Summary: antiviral treatment of hepatitis C virus. Antiviral research, 1996, Volume: 29, Issue:1 Topics: Acute Disease; Antiviral Agents; Chronic Disease; Drug Therapy, Combination; Hepatitis C; Humans; Interferon-alpha; Liver Transplantation; Ribavirin	1996
Treatment of chronic hepatitis C: another therapeutic option. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1996, Volume: 11 Suppl 4 Topics: Antiviral Agents; Chronic Disease; Hepacivirus; Hepatitis C; Humans; Interferons; Liver Transplantation; Polymerase Chain Reaction; Recurrence; Ribavirin; RNA, Viral; Treatment Outcome	1996
Interferon-ribavirin combination therapy for chronic hepatitis C. Digestive diseases and sciences, 1996, Volume: 41, Issue:12 Suppl Topics: Antiviral Agents; Chronic Disease; Drug Therapy, Combination; Hepatitis C; Humans; Interferon-alpha; Randomized Controlled Trials as Topic; Ribavirin	1996
[Treatment of chronic hepatitis C: still many problems pending]. Gastroenterologia y hepatologia, 1997, Volume: 20, Issue:1 Topics: Adrenal Cortex Hormones; Aged; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Cholagogues and Choleretics; Chronic Disease; Clinical Enzyme Tests; Drug Therapy, Combination; Hepatitis C; HIV Infections; Humans; Indomethacin; Interferons; Ofloxacin; Phlebotomy; Recurrence; Ribavirin; Time Factors; Ursodeoxycholic Acid	1997
Viral hepatitis: how to manage type C and D infections. Geriatrics, 1997, Volume: 52, Issue:5 Topics: Acute Disease; Aged; Antiviral Agents; Chronic Disease; Disease Progression; Hepatitis B; Hepatitis C; Hepatitis D; Humans; Interferon alpha-2; Interferon-alpha; Recombinant Proteins; Ribavirin	1997
Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C. Meta-analysis of individual patient data from European centers. Journal of hepatology, 1997, Volume: 26, Issue:5 Topics: Adult; Alanine Transaminase; Chronic Disease; Drug Synergism; Drug Therapy, Combination; Female; Hemoglobins; Hepacivirus; Hepatitis C; Humans; Interferons; Male; Middle Aged; Randomized Controlled Trials as Topic; Ribavirin; RNA, Viral	1997
Moving towards the optimal treatment of chronic hepatitis C. Italian journal of gastroenterology and hepatology, 1997, Volume: 29, Issue:1 Topics: Antiviral Agents; Chronic Disease; Drug Therapy, Combination; Hepatitis C; Humans; Interferons; Ribavirin	1997
[Update on hepatitis C: potential transmission by invasive medical examinations; new therapeutic modalities (1)]. Revue medicale de Liege, 1998, Volume: 53, Issue:8 Topics: Acute Disease; Antiviral Agents; Chronic Disease; Combined Modality Therapy; Cross Infection; Disease Progression; Hepatitis C; Humans; Interferons; Ribavirin	1998
[Current approaches to the treatment of chronic viral liver diseases]. Terapevticheskii arkhiv, 2000, Volume: 72, Issue:8 Topics: Antiviral Agents; Chronic Disease; Drug Therapy, Combination; Glucocorticoids; Hepatitis, Viral, Human; Humans; Interferon alpha-2; Interferon-alpha; Recombinant Proteins; Ribavirin; Secondary Prevention; Treatment Outcome	2000
An emerging role for interferon in haemophiliacs with chronic hepatitis C? Haemophilia : the official journal of the World Federation of Hemophilia, 2001, Volume: 7, Issue:1 Topics: Antiviral Agents; Chronic Disease; Hemophilia A; Hepatitis C; Humans; Interferons; Ribavirin	2001
Neuropsychiatric toxicity of antiviral treatment in chronic hepatitis C. Digestive diseases (Basel, Switzerland), 2000, Volume: 18, Issue:3 Topics: Antiviral Agents; Anxiety; Chronic Disease; Cognition; Depression; Drug Therapy, Combination; Hepatitis C; Humans; Interferon-alpha; Ribavirin; Sleep Initiation and Maintenance Disorders	2000

Trials

24 trial(s) available for ribavirin and Chronic Disease

Article	Year
Retention rate and side effects in a prospective trial on hepatitis C treatment with pegylated interferon alpha-2a and ribavirin in opioid-dependent patients. Addiction biology, 2009, Volume: 14, Issue:2 Topics: Adolescent; Adult; Aged; Antiviral Agents; Chronic Disease; Female; Genotype; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Opioid-Related Disorders; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Retention, Psychology; Ribavirin; Young Adult	2009
A monocentric observational study of darbepoetin alfa in anemic hepatitis-C-virus transplant patients treated with ribavirin. Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2008, Volume: 6, Issue:4 Topics: Anemia; Antiviral Agents; Chronic Disease; Creatinine; Darbepoetin alfa; Erythropoietin; Female; Hematinics; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Liver Transplantation; Male; Pilot Projects; Postoperative Care; Prospective Studies; Retrospective Studies; Ribavirin; RNA, Viral; Treatment Outcome	2008
Long term histological improvement and clearance of intrahepatic hepatitis C virus RNA following sustained response to interferon-ribavirin combination therapy in liver transplanted patients with hepatitis C virus recurrence. Gut, 2003, Volume: 52, Issue:2 Topics: Adult; Aged; Alanine Transaminase; Antiviral Agents; Chronic Disease; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C; Humans; Interferons; Liver; Liver Transplantation; Male; Middle Aged; Polymerase Chain Reaction; Recurrence; Ribavirin; RNA, Viral; Treatment Outcome	2003
Antiviral therapy decreases GpIIb/IIIa activation of platelets in patients with chronic hepatitis C. Thrombosis and haemostasis, 2006, Volume: 95, Issue:2 Topics: Adult; Aged; Antiviral Agents; Biomarkers; Case-Control Studies; Chronic Disease; Drug Therapy, Combination; Female; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Platelet Activation; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Polyethylene Glycols; Recombinant Proteins; Ribavirin; von Willebrand Factor	2006
Effect of the interleukin-6 C174G gene polymorphism on treatment of acute and chronic hepatitis C in human immunodeficiency virus coinfected patients. Hepatology (Baltimore, Md.), 2007, Volume: 46, Issue:4 Topics: Acute Disease; Adult; Aged; Antiviral Agents; Cell Line, Tumor; Chronic Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Genotype; Hepatitis C; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Interleukin-6; Male; Middle Aged; Polyethylene Glycols; Polymorphism, Single Nucleotide; Recombinant Proteins; Ribavirin; STAT3 Transcription Factor; Treatment Outcome	2007
Interferon and ribavirin with or without amantadine for interferon non-responders with chronic hepatitis C. A randomized, controlled pilot study. Swiss medical weekly, 2007, Jul-28, Volume: 137, Issue:29-30 Topics: Adolescent; Adult; Aged; Amantadine; Chronic Disease; Drug Therapy, Combination; Female; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Recombinant Proteins; Ribavirin; Treatment Failure; Treatment Outcome	2007
Ribavirin for respiratory syncytial virus bronchiolitis reduced the risk of asthma and allergen sensitization. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 2008, Volume: 19, Issue:2 Topics: Antiviral Agents; Asthma; Bronchiolitis, Viral; Child; Child, Preschool; Chronic Disease; Cohort Studies; Female; Follow-Up Studies; Heart Defects, Congenital; Humans; Hypersensitivity; Infant; Lung Diseases; Male; Respiratory Syncytial Virus Infections; Ribavirin; Risk; Risk Factors; Taiwan; Time	2008
Ribavirin as therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. Annals of internal medicine, 1995, Dec-15, Volume: 123, Issue:12 Topics: Administration, Oral; Adult; Aged; Alanine Transaminase; Antiviral Agents; Chronic Disease; Double-Blind Method; Drug Administration Schedule; Female; Hepacivirus; Hepatitis C; Humans; Male; Middle Aged; Ribavirin; RNA, Viral	1995
A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C. Gastroenterology, 1994, Volume: 107, Issue:3 Topics: Adult; Alanine Transaminase; Chronic Disease; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Liver; Male; Middle Aged; Pilot Projects; Ribavirin; RNA	1994
Antiviral therapy in neonatal chronic lung disease. Early human development, 1995, Jun-21, Volume: 42, Issue:2 Topics: Administration, Inhalation; Antiviral Agents; Chronic Disease; Female; Follow-Up Studies; Humans; Infant, Newborn; Infant, Premature, Diseases; Lung; Lung Diseases; Male; Respiration; Respiratory Function Tests; Ribavirin	1995
Combined treatment with interferon alpha-2b and ribavirin for chronic hepatitis C in patients with a previous non-response or non-sustained response to interferon alone. Journal of medical virology, 1995, Volume: 46, Issue:1 Topics: Adult; Aged; Alanine Transaminase; Chronic Disease; Drug Therapy, Combination; Female; Follow-Up Studies; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Pilot Projects; Recombinant Proteins; Ribavirin; RNA, Viral	1995
Therapy of chronic hepatitis B with a 6-month course of ribavirin. Journal of hepatology, 1994, Volume: 21, Issue:2 Topics: Administration, Oral; Adult; Alanine Transaminase; Chronic Disease; Cohort Studies; DNA, Viral; Dose-Response Relationship, Drug; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Male; Middle Aged; Nucleosides; Ribavirin; Time Factors; Virus Replication	1994
Ribavirin therapy in chronic delta hepatitis. Journal of hepatology, 1993, Volume: 19, Issue:2 Topics: Chronic Disease; Dose-Response Relationship, Drug; Double-Blind Method; Hepatitis D; Humans; Ribavirin; Time Factors	1993
Pilot study of ribavirin and interferon-beta for chronic hepatitis B. Hepatology (Baltimore, Md.), 1993, Volume: 18, Issue:2 Topics: Adult; Alanine Transaminase; Chronic Disease; DNA-Directed DNA Polymerase; DNA, Viral; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Interferon-beta; Male; Middle Aged; Pilot Projects; Ribavirin	1993
A pilot study of ribavirin and interferon beta for the treatment of chronic hepatitis C. Gastroenterology, 1993, Volume: 105, Issue:2 Topics: Adult; Chronic Disease; Female; Hepacivirus; Hepatitis C; Humans; Interferon-beta; Male; Middle Aged; Pilot Projects; Ribavirin; RNA, Viral	1993
Long-term efficacy of ribavirin plus interferon alfa in the treatment of chronic hepatitis C. Gastroenterology, 1996, Volume: 111, Issue:5 Topics: Adult; Aged; Alanine Transaminase; Chronic Disease; Drug Therapy, Combination; Female; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Liver; Male; Middle Aged; Recombinant Proteins; Ribavirin; RNA, Viral	1996
Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study. Journal of hepatology, 1996, Volume: 25, Issue:5 Topics: Administration, Oral; Adolescent; Adult; Aged; Alanine Transaminase; Antiviral Agents; Biopsy; Chronic Disease; Double-Blind Method; Female; Genotype; Hepacivirus; Hepatitis C; Humans; Male; Middle Aged; Ribavirin; Treatment Outcome	1996
Ribavirin and interferon-alpha combination therapy vs interferon-alpha alone in the retreatment of chronic hepatitis C: a randomized clinical trial. Journal of viral hepatitis, 1997, Volume: 4, Issue:3 Topics: Adult; Aged; Antiviral Agents; Chronic Disease; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C; Humans; Interferon-alpha; Male; Middle Aged; Ribavirin; Treatment Outcome	1997
Effect of interferon-alpha and ribavirin therapy on serum GB virus C/hepatitis G virus (GBV-C/HGV) RNA levels in patients chronically infected with hepatitis C virus and GBV-C/HGV. The Journal of infectious diseases, 1997, Volume: 176, Issue:2 Topics: Adult; Alanine Transaminase; Antiviral Agents; Chronic Disease; DNA, Viral; Drug Therapy, Combination; Female; Flaviviridae; Genetic Techniques; Hepatitis C; Hepatitis, Viral, Human; Humans; Interferon Type I; Liver; Male; Middle Aged; Molecular Sequence Data; Phylogeny; Polymerase Chain Reaction; Recombinant Proteins; Ribavirin; RNA, Viral; Sensitivity and Specificity; Sequence Analysis, DNA; Viremia	1997
Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: a multicenter trial. Hepatology (Baltimore, Md.), 1997, Volume: 26, Issue:2 Topics: Administration, Oral; Adult; Aged; Antiviral Agents; Chronic Disease; Double-Blind Method; Female; Hepatitis C; Humans; Male; Middle Aged; Ribavirin	1997
Recovery from chronic hepatitis C in long-term responders to ribavirin plus interferon alfa. Lancet (London, England), 2000, Jul-01, Volume: 356, Issue:9223 Topics: Alanine Transaminase; Antiviral Agents; Biopsy; Chronic Disease; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Liver; Male; Middle Aged; Polymerase Chain Reaction; Predictive Value of Tests; Ribavirin; RNA, Viral; Treatment Outcome	2000
The effect of ribavirin to treat previously healthy infants admitted with acute bronchiolitis on acute and chronic respiratory morbidity. Respiratory medicine, 2001, Volume: 95, Issue:4 Topics: Antiviral Agents; Bronchial Provocation Tests; Bronchiolitis, Viral; Chronic Disease; Double-Blind Method; Female; Humans; Infant; Least-Squares Analysis; Length of Stay; Male; Normal Distribution; Plethysmography, Whole Body; Ribavirin; Severity of Illness Index; Treatment Outcome	2001
Predicting response to initial therapy with interferon plus ribavirin in chronic hepatitis C using serum HCV RNA results during therapy. Journal of viral hepatitis, 2001, Volume: 8, Issue:6 Topics: Alanine Transaminase; Antiviral Agents; Chronic Disease; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C Antibodies; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Predictive Value of Tests; Ribavirin; RNA, Viral; Time Factors	2001
Trial of ribavirin for the treatment of HBsAg positive chronic liver disease. The Journal of antimicrobial chemotherapy, 1978, Volume: 4, Issue:4 Topics: Adult; Chronic Disease; Hepatitis B; Hepatitis B Surface Antigens; Humans; Male; Middle Aged; Ribavirin; Ribonucleosides; Time Factors	1978

Other Studies

51 other study(ies) available for ribavirin and Chronic Disease

Article	Year
Recurrent Chronic HEV in Severe Combined Immunodeficiency. Journal of clinical immunology, 2021, Volume: 41, Issue:5 Topics: Adult; Antibodies, Viral; Antiviral Agents; Chronic Disease; Female; Hepatitis E; Hepatitis E virus; Humans; Immunoglobulin G; Immunoglobulin M; Janus Kinase 3; Recurrence; Ribavirin; RNA, Viral; Severe Combined Immunodeficiency; T-Lymphocytes	2021
Ribavirin treatment of a patient with chronic hepatitis E.\ First case reported in Latin America. Acta gastroenterologica Latinoamericana, 2016, Volume: 46, Issue:2 Topics: Adult; Antiviral Agents; Biomarkers; Chronic Disease; Hepatitis Antibodies; Hepatitis E; Hepatitis E virus; Humans; Kidney Transplantation; Male; Ribavirin	2016
Chronic hepatitis E in a heart transplant patient: sofosbuvir and ribavirin regimen not fully effective. Antiviral therapy, 2018, Volume: 23, Issue:5 Topics: Antiviral Agents; Cardiomyopathy, Dilated; Chronic Disease; Drug Therapy, Combination; Heart Transplantation; Hepatitis E; Hepatitis E virus; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Ribavirin; Sofosbuvir; Treatment Failure	2018
Ribavirin therapy of hepatitis E infection may cause hyporegenerative anemia in pediatric renal transplant patients. Pediatric transplantation, 2018, Volume: 22, Issue:4 Topics: Adolescent; Anemia; Antiviral Agents; Chronic Disease; Female; Hepatitis E; Humans; Kidney Transplantation; Postoperative Complications; Ribavirin	2018
Monitoring hepatitis E virus fecal shedding to optimize ribavirin treatment duration in chronically infected transplant patients. Journal of hepatology, 2019, Volume: 70, Issue:1 Topics: Aged; Antiviral Agents; Chronic Disease; Duration of Therapy; Feces; Female; Genotype; Hepatitis E; Hepatitis E virus; Humans; Male; Middle Aged; Organ Transplantation; Ribavirin; RNA, Viral	2019
Successful treatment with ribavirine for chronic hepatitis E in chronic lymphocytic leukemia treated with Ibrutinib. Bulletin du cancer, 2019, Volume: 106, Issue:1 Topics: Adenine; Aged; Alemtuzumab; Antineoplastic Agents, Immunological; Antiviral Agents; Chronic Disease; Disease Progression; Hepatitis E; Hepatitis E virus; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Piperidines; Pyrazoles; Pyrimidines; Ribavirin	2019
Failure to respond to ribavirin despite elevated intra-erythrocyte zinc level in transplant-patients with chronic hepatitis E virus infection. Transplant infectious disease : an official journal of the Transplantation Society, 2019, Volume: 21, Issue:2 Topics: Antiviral Agents; Chronic Disease; Erythrocytes; Female; Hepatitis E; Hepatitis E virus; Humans; Immunocompromised Host; Middle Aged; Ribavirin; RNA, Viral; Transplant Recipients; Treatment Failure; Zinc	2019
Sofosbuvir add-on to ribavirin for chronic hepatitis E in a cirrhotic liver transplant recipient: a case report. BMC gastroenterology, 2019, May-24, Volume: 19, Issue:1 Topics: Antiviral Agents; Chronic Disease; Drug Therapy, Combination; Hepatitis E; Humans; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Postoperative Period; Ribavirin; Sofosbuvir	2019
Perspectives of a self-selected sample of former patients on the long-term health outcomes of interferon-based hepatitis C treatments: an exploratory study. Psychology, health & medicine, 2013, Volume: 18, Issue:6 Topics: Adult; Aftercare; Anorexia; Antiviral Agents; Attitude of Health Personnel; Chronic Disease; Cognition Disorders; Depression; Female; Hepatitis C; Humans; Interferon-alpha; Male; Middle Aged; Neurotoxicity Syndromes; New South Wales; Patient Education as Topic; Qualitative Research; Quality of Life; Recurrence; Ribavirin; Sarcoidosis; Self Report; Severity of Illness Index; Treatment Outcome; Victoria	2013
Course and treatment of chronic hepatitis E virus infection in lung transplant recipients. Transplant infectious disease : an official journal of the Transplantation Society, 2014, Volume: 16, Issue:2 Topics: Adult; Aged; Alanine Transaminase; Antiviral Agents; Chronic Disease; Female; Hepatitis E; Hepatitis E virus; Humans; Immunoglobulin G; Lung Transplantation; Male; Middle Aged; Retrospective Studies; Ribavirin; RNA, Viral; Seroepidemiologic Studies; Virus Replication; Young Adult	2014
Chronic hepatitis E virus infection: challenges in diagnosis and recognition in the United States. Journal of clinical gastroenterology, 2015, Volume: 49, Issue:1 Topics: Adult; Antibodies, Viral; Chronic Disease; Hepatitis E; Hepatitis E virus; Humans; Immunoglobulin G; Immunoglobulin M; Kidney Transplantation; Male; Ribavirin; RNA, Viral; United States	2015
Treatment of persistent rhinovirus infection with pegylated interferon α2a and ribavirin in patients with hypogammaglobulinemia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014, Volume: 58, Issue:12 Topics: Agammaglobulinemia; Antiviral Agents; Chronic Disease; Common Variable Immunodeficiency; Drug Therapy, Combination; Humans; Interferon-alpha; Male; Middle Aged; Picornaviridae Infections; Polyethylene Glycols; Recombinant Proteins; Rhinovirus; Ribavirin	2014
Ribavirin for chronic hepatitis E virus infection in transplant recipients. The New England journal of medicine, 2014, Mar-20, Volume: 370, Issue:12 Topics: Adult; Aged; Antiviral Agents; Chronic Disease; Drug Administration Schedule; Female; Hepatitis E; Hepatitis E virus; Humans; Male; Middle Aged; Organ Transplantation; Retrospective Studies; Ribavirin; Viral Load; Virus Replication	2014
Patient-reported outcomes in chronic hepatitis C patients with cirrhosis treated with sofosbuvir-containing regimens. Hepatology (Baltimore, Md.), 2014, Volume: 59, Issue:6 Topics: Adult; Antiviral Agents; Chronic Disease; Clinical Trials, Phase III as Topic; Drug Therapy, Combination; Female; Hepatitis C; Humans; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Polyethylene Glycols; Quality of Life; Recombinant Proteins; Retrospective Studies; Ribavirin; Sofosbuvir; Treatment Outcome; Uridine Monophosphate	2014
Hepatitis E-associated encephalopathy in a renal transplant recipient. BMJ case reports, 2014, Apr-30, Volume: 2014 Topics: Aged; Biopsy, Needle; Chronic Disease; Disease Progression; Electromyography; Female; Follow-Up Studies; Graft Survival; Hepatic Encephalopathy; Hepatitis E; Humans; Immunocompromised Host; Immunohistochemistry; Kidney Failure, Chronic; Kidney Transplantation; Liver Function Tests; Magnetic Resonance Imaging; Ribavirin; Severity of Illness Index; Transplant Recipients; Transplantation Immunology; Treatment Outcome; Viral Load	2014
The role of chronic norovirus infection in the enteropathy associated with common variable immunodeficiency. The American journal of gastroenterology, 2015, Volume: 110, Issue:2 Topics: Adult; Aged; Antiviral Agents; Biopsy; Caliciviridae Infections; Case-Control Studies; Chronic Disease; Cohort Studies; Common Variable Immunodeficiency; Duodenum; Feces; Female; Humans; Intestinal Diseases; Intestine, Small; Male; Middle Aged; Norovirus; Ribavirin; RNA, Viral	2015
Chronic hepatitis E infection with an emerging virus strain in a heart transplant recipient successfully treated with ribavirin: a case report. Journal of medical case reports, 2015, Aug-26, Volume: 9 Topics: Antiviral Agents; Chronic Disease; Heart Transplantation; Hepatitis E; Humans; Immunocompromised Host; Male; Middle Aged; Polymerase Chain Reaction; Ribavirin	2015
Sofosbuvir Inhibits Hepatitis E Virus Replication In Vitro and Results in an Additive Effect When Combined With Ribavirin. Gastroenterology, 2016, Volume: 150, Issue:1 Topics: Antiviral Agents; Chronic Disease; Drug Synergism; Drug Therapy, Combination; Hepatitis E; Hepatitis E virus; Humans; In Vitro Techniques; Ribavirin; RNA, Viral; Sofosbuvir; Virus Replication	2016
In vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genome. Gut, 2016, Volume: 65, Issue:10 Topics: Adolescent; Adult; Aged; Antiviral Agents; Chronic Disease; Drug Monitoring; Female; Genetic Heterogeneity; Genome, Viral; Hepatitis E; Hepatitis E virus; Humans; Male; Middle Aged; Mutagenesis; Ribavirin	2016
[A murine model for an ignored chronic infection: hepatitis E !] Medecine sciences : M/S, 2016, Volume: 32, Issue:10 Topics: Animals; Chronic Disease; Disease Models, Animal; Hepatitis E; Hepatocytes; Heterografts; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Mice, Transgenic; Ribavirin; Urokinase-Type Plasminogen Activator	2016
Brief communication: case reports of ribavirin treatment for chronic hepatitis E. Annals of internal medicine, 2010, Jul-20, Volume: 153, Issue:2 Topics: Administration, Oral; Adult; Antiviral Agents; Chronic Disease; Female; Hepatitis E; Humans; Immunocompromised Host; Kidney Transplantation; Male; Middle Aged; Pancreas Transplantation; Ribavirin; T-Lymphocytopenia, Idiopathic CD4-Positive	2010
Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection. Gastroenterology, 2010, Volume: 139, Issue:5 Topics: Aged; Antiviral Agents; Chronic Disease; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Hepatitis Antibodies; Hepatitis E; Hepatitis E virus; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Pilot Projects; Retrospective Studies; Ribavirin; RNA, Viral; Treatment Outcome; Virus Replication	2010
Sustained virologic response with ribavirin in chronic hepatitis E virus infection in heart transplantation. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2011, Volume: 30, Issue:7 Topics: Alanine Transaminase; Antiviral Agents; Aspartate Aminotransferases; Chronic Disease; Follow-Up Studies; Heart Transplantation; Hepatitis E; Humans; Male; Middle Aged; Ribavirin; RNA, Viral; Treatment Outcome	2011
Genetic polymorphism of low-density lipoprotein receptor did not affect treatment outcome of chronic hepatitis C genotype 3. Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2011, Volume: 94 Suppl 1 Topics: Aged; Aged, 80 and over; Alanine Transaminase; Antiviral Agents; Chronic Disease; Female; Follow-Up Studies; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferons; Male; Middle Aged; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Receptors, LDL; Ribavirin; RNA, Viral; Treatment Outcome	2011
Definitive clearance of a chronic hepatitis E virus infection with ribavirin treatment. The American journal of gastroenterology, 2011, Volume: 106, Issue:8 Topics: Aged; Alanine Transaminase; Antibodies; Antiviral Agents; Biomarkers; Chronic Disease; Female; Hepatitis E; Hepatitis E virus; Humans; Immunoglobulin A; Immunoglobulin M; Leukemia, Myelomonocytic, Chronic; Ribavirin; Thrombocytopenia; Treatment Outcome; Viral Load	2011
[Therapy of viral hepatitis]. Therapeutische Umschau. Revue therapeutique, 2003, Volume: 60, Issue:10 Topics: Antiviral Agents; Chronic Disease; Hepatitis, Viral, Human; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Function Tests; Polyethylene Glycols; Prognosis; Recombinant Proteins; Ribavirin; Viral Load	2003
Hepatitis C: treatment challenges. Professional nurse (London, England), 2003, Volume: 19, Issue:3 Topics: Antiviral Agents; Chronic Disease; Disease Progression; Drug Monitoring; Drug Therapy, Combination; Hepatitis C; Humans; Interferon-alpha; Patient Education as Topic; Ribavirin; Treatment Outcome	2003
Alpha interferon and ribavirin combination therapy of chronic hepatitis D. Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:3 Topics: Adult; Antiviral Agents; Chronic Disease; Drug Therapy, Combination; Female; Hepatitis D; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Prospective Studies; Recombinant Proteins; Ribavirin	2005
The optimal treatment strategy for chronic hepatitis C. Medical hypotheses, 2005, Volume: 65, Issue:2 Topics: Antiviral Agents; Chronic Disease; Hepatitis C; Humans; Interferons; Models, Theoretical; Polyethylene Glycols; Recurrence; Ribavirin; Time Factors; Treatment Outcome	2005
Onset of type 1 diabetes mellitus during peginterferon alpha-2b plus ribavirin treatment for chronic hepatitis C. European journal of gastroenterology & hepatology, 2006, Volume: 18, Issue:6 Topics: Antiviral Agents; Autoimmunity; Chronic Disease; Combined Modality Therapy; Diabetes Mellitus, Type 1; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome	2006
Rapid onset of ulcerative colitis after treatment with PEG-interferon plus ribavirin for chronic hepatitis C. Inflammatory bowel diseases, 2007, Volume: 13, Issue:9 Topics: Antiviral Agents; Chronic Disease; Colitis, Ulcerative; Edema; Genotype; Hepatitis C; Humans; Immune System; Interferon alpha-2; Interferon-alpha; Interferons; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin	2007
[A case of peripheral facial nerve palsy with cryoglobulinemia and chronic thyroiditis occurring during interferon plus ribavirin therapy for chronic hepatitis C]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2007, Volume: 104, Issue:6 Topics: Adult; Antiviral Agents; Chronic Disease; Cryoglobulinemia; Facial Paralysis; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Recombinant Proteins; Ribavirin; Thyroiditis	2007
Changes in hepatitis C virus antigen in liver with antiviral therapy. Gastroenterology, 1993, Volume: 105, Issue:3 Topics: Adult; Aged; Alanine Transaminase; Antigens, Viral; Biopsy; Chronic Disease; Enzyme-Linked Immunosorbent Assay; Female; Fluorescent Antibody Technique; Hepacivirus; Hepatitis C; Hepatitis C Antigens; Humans; Interferon-alpha; Liver; Male; Middle Aged; Polymerase Chain Reaction; Ribavirin; RNA, Viral; Virus Replication	1993
Increase in hepatic iron stores following prolonged therapy with ribavirin in patients with chronic hepatitis C. Journal of hepatology, 1994, Volume: 21, Issue:6 Topics: Adult; Aged; Alanine Transaminase; Chronic Disease; Female; Hematocrit; Hepatitis C; Humans; Iron; Liver; Male; Middle Aged; Pilot Projects; Ribavirin; Time Factors	1994
[Half of the patients respond to interferon treatment. Combination therapy is an alternative in chronic hepatitis C]. Lakartidningen, 1995, May-03, Volume: 92, Issue:18 Topics: Chronic Disease; Contraindications; Drug Therapy, Combination; Hepatitis C; Humans; Interferon-alpha; Prognosis; Ribavirin	1995
Treatment of chronic hepatitis C. Scandinavian journal of infectious diseases. Supplementum, 1994, Volume: 95 Topics: Administration, Oral; Adult; Aged; Alanine Transaminase; Base Sequence; Chronic Disease; Drug Administration Schedule; Female; Follow-Up Studies; Hepacivirus; Hepatitis C; Humans; Injections, Subcutaneous; Interferon-alpha; Liver; Male; Middle Aged; Molecular Sequence Data; Ribavirin; RNA, Viral; Treatment Outcome	1994
Clinical features of chronic hepatitis C. Transplantation proceedings, 1994, Volume: 26, Issue:6 Topics: Chronic Disease; Genotype; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Liver Transplantation; Ribavirin; RNA, Viral	1994
Ribavirin in the treatment of chronic hepatitis C unresponsive to alfa interferon. Journal of hepatology, 1993, Volume: 19, Issue:3 Topics: Adult; Aged; Base Sequence; Chronic Disease; Female; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Male; Middle Aged; Molecular Sequence Data; Ribavirin; Transaminases	1993
Hepatitis C viral RNA titers in serum prior to, during, and after oral treatment with ribavirin for chronic hepatitis C. Journal of medical virology, 1993, Volume: 41, Issue:2 Topics: Administration, Oral; Alanine Transaminase; Base Sequence; Chronic Disease; DNA, Viral; Female; Hepacivirus; Hepatitis C; Humans; Male; Molecular Sequence Data; Polymerase Chain Reaction; Ribavirin; RNA, Viral	1993
Introduction: combination antiviral therapy in chronic hepatitis C. Journal of hepatology, 1995, Volume: 23 Suppl 2 Topics: Adult; Antiviral Agents; Child; Chronic Disease; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; Humans; Interferons; Male; Ribavirin	1995
[Ribavirin treatment in patients with chronic hepatitis C refractory to interferon-alpha]. Gastroenterologia y hepatologia, 1996, Volume: 19, Issue:5 Topics: Adult; Anemia; Antiviral Agents; Chronic Disease; Drug Evaluation; Hepatitis C; Humans; Interferon-alpha; Male; Middle Aged; Ribavirin; Transaminases	1996
Ribavirin for chronic hepatitis C. Annals of internal medicine, 1996, Oct-15, Volume: 125, Issue:8 Topics: Antiviral Agents; Chronic Disease; Hepatitis C; Humans; Lamivudine; Ribavirin; Zalcitabine	1996
Chronic HCV infection: public health threat and emerging consensus. Vienna, Austria, October 27-28, 1995. Digestive diseases and sciences, 1996, Volume: 41, Issue:12 Suppl Topics: Antiviral Agents; Chronic Disease; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Recombinant Proteins; Ribavirin	1996
Interferon-associated thyroid dysfunction in anti-D-related chronic hepatitis C. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, 1997, Volume: 17, Issue:7 Topics: Antiviral Agents; Chronic Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Genotype; Hepatitis C; Humans; Interferons; Retrospective Studies; Rho(D) Immune Globulin; Ribavirin; Thyroid Diseases	1997
[The effect of interferon in combination with ribavirin on the plus and minus strands of hepatitis C virus RNA in patients with hepatitis]. Zhonghua nei ke za zhi, 1996, Volume: 35, Issue:1 Topics: Adult; Antiviral Agents; Chronic Disease; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Recombinant Proteins; Ribavirin; RNA, Double-Stranded; RNA, Viral	1996
Effects of cirrhosis, interferon and azathioprine on adverse events in patients with chronic hepatitis C treated with ribavirin. Journal of viral hepatitis, 1997, Volume: 4, Issue:4 Topics: Adult; Aged; Anemia; Antiviral Agents; Azathioprine; Chronic Disease; Contraindications; Drug Therapy, Combination; Female; Hemoglobins; Hemolysis; Hepatitis C; Humans; Immunosuppressive Agents; Interferons; Liver Cirrhosis; Male; Middle Aged; Platelet Count; Retrospective Studies; Ribavirin	1997
The single dose pharmacokinetics of ribavirin in subjects with chronic liver disease. British journal of clinical pharmacology, 2000, Volume: 49, Issue:5 Topics: Adult; Chronic Disease; Female; Humans; Liver Diseases; Male; Middle Aged; Ribavirin	2000
Treatment with interferon plus ribavirin in anti-HIV negative patients with congenital coagulation disorders and chronic hepatitis C. Thrombosis and haemostasis, 2000, Volume: 83, Issue:6 Topics: Adolescent; Adult; Age Factors; Age of Onset; Alanine Transaminase; Antiviral Agents; Blood Coagulation Disorders; Child; Chronic Disease; Drug Therapy, Combination; Factor VII Deficiency; Female; Hemoglobins; Hemophilia A; Hemophilia B; Hepacivirus; Hepatitis C; HIV Antibodies; HIV Seronegativity; Humans; Interferons; Male; Middle Aged; Neutrophils; Platelet Count; Predictive Value of Tests; Prognosis; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; RNA, Viral; Sensitivity and Specificity; Treatment Outcome; von Willebrand Diseases	2000
[Chronic liver diseases. The nihilism has gone]. MMW Fortschritte der Medizin, 2001, Dec-13, Volume: 143, Issue:51-52 Topics: Amantadine; Antioxidants; Antiviral Agents; Chronic Disease; Dipeptides; Drug Therapy, Combination; Flumazenil; GABA Modulators; Hepatic Encephalopathy; Hepatitis C, Chronic; Humans; Interferons; Liver Cirrhosis; Liver Diseases; Pentoxifylline; Phosphodiesterase Inhibitors; Prospective Studies; Protective Agents; Ribavirin; Silymarin	2001
Effect of ribavirin on murine cytomegalovirus infection. Antimicrobial agents and chemotherapy, 1976, Volume: 10, Issue:5 Topics: Acute Disease; Animals; Cells, Cultured; Chronic Disease; Cytomegalovirus Infections; Cytopathogenic Effect, Viral; In Vitro Techniques; Mice; Ribavirin; Ribonucleosides; Viral Plaque Assay	1976
Bronchiolitis. Pediatric annals, 1986, Volume: 15, Issue:4 Topics: Adrenal Cortex Hormones; Adult; Airway Obstruction; Anti-Bacterial Agents; Apnea; Bronchiolitis, Viral; Bronchodilator Agents; Child, Preschool; Chronic Disease; Humans; Infant; Infant, Newborn; Respiration; Ribavirin	1986